Use of PD-1 inhibitors in patients with end-stage renal disease: safety and clinical outcomes from real-world data

被引：4
|
作者：
Wang, Jiasheng [1 ]
Dasari, Srilatha [2 ]
Elantably, Dina [2 ]
Alkrekshi, Akram [2 ]
Kim, Yeseong David [3 ]
机构：
[1] Univ Hosp Cleveland, Seidman Canc Ctr, Med Ctr, Dept Hematol & Oncol, 11100 Euclid Ave, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Dept Internal Med, MetroHlth Med Ctr, Cleveland, OH 44106 USA
[3] Temple Univ, Sect Gastroenterol, Dept Med, Philadelphia, PA 19122 USA
来源：
ACTA ONCOLOGICA | 2022年 / 61卷 / 09期
关键词：
CHECKPOINT INHIBITORS; CANCER-PATIENTS; KIDNEY-DISEASE; TOXICITIES;
D O I：
10.1080/0284186X.2022.2127121
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1157 / 1161
页数：5
相关论文
共 50 条
  • [1] Safety and pharmacokinetic profile of apixaban in end-stage renal disease: A real-world analysis
    Tseng, Chen I.
    Roddick, Alistair J.
    Bottomley, Matthew J.
    Shapiro, Susan
    Udayaraj, Udaya
    EJHAEM, 2023, 4 (01): : 291 - 293
  • [2] Safety and Efficacy of Immune Checkpoint Inhibitors for Patients With Metastatic Urothelial Carcinoma and End-Stage Renal Disease: Experiences From Real-World Practice
    Kuo, Ming-Chun
    Su, Po-Jung
    Huang, Chun-Chieh
    Luo, Hao-Lun
    Chiu, Tai-Jan
    Li, Shau-Hsuan
    Wu, Chia-Che
    Liu, Ting-Ting
    Cheng, Yuan-Tso
    Kang, Chih-Hsiung
    Su, Yu-Li
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [3] REAL-WORLD TREATMENT AND CLINICAL OUTCOMES IN END-STAGE RENAL DISEASE PATIENTS WITH SEVERE HYPERKALEMIA UNDERGOING HEMODIALYSIS IN THE UNITED STATES
    Chatoth, Dinesh
    Wahl, Peter
    Rakov, Viatcheslav
    Van Zandt, Carly
    Anastassopoulos, Kathryn
    Colman, Sam
    Knight, Tyler
    Romero, Alain
    Mooney, Ann
    Spiegel, David
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 : 218 - 218
  • [4] REAL-WORLD OUTCOMES OF HYPERKALEMIA MANAGEMENT WITH PATIROMER IN END-STAGE RENAL DISEASE PATIENTS UNDERGOING HEMODIALYSIS IN THE UNITED STATES
    Chatoth, Dinesh
    Wahl, Peter
    Rakov, Viatcheslav
    Van Zandt, Carly
    Anastassopoulos, Kathryn
    Colman, Sam
    Knight, Tyler
    Oestreicher, Nina
    Mooney, Ann
    Spiegel, David
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 657 - +
  • [5] Risk of End-Stage Renal Disease in Psoriatic Patients: Real-World Data from a Nationwide Population-Based Cohort Study
    Eun Lee
    Ju Hee Han
    Chul Hwan Bang
    Seung Ah Yoo
    Kyung Do Han
    Ha-Na Kim
    Young Min Park
    Jun Young Lee
    Ji Hyun Lee
    Scientific Reports, 9
  • [6] Risk of End-Stage Renal Disease in Psoriatic Patients: Real-World Data from a Nationwide Population- Based Cohort Study
    Lee, Eun
    Han, Ju Hee
    Bang, Chul Hwan
    Yoo, Seung Ah
    Do Han, Kyung
    Kim, Ha-Na
    Park, Young Min
    Lee, Jun Young
    Lee, Ji Hyun
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [7] Real-world evidence and optimization of vocal dysfunction in end-stage renal disease patients with secondary hyperparathyroidism
    Geng-He Chang
    Fong-Fu Chou
    Ming-Shao Tsai
    Yao-Te Tsai
    Ming-Yu Yang
    Ethan I. Huang
    Hui-Chen Su
    Cheng-Ming Hsu
    Scientific Reports, 11
  • [8] Real-world evidence and optimization of vocal dysfunction in end-stage renal disease patients with secondary hyperparathyroidism
    Chang, Geng-He
    Chou, Fong-Fu
    Tsai, Ming-Shao
    Tsai, Yao-Te
    Yang, Ming-Yu
    Huang, Ethan, I
    Su, Hui-Chen
    Hsu, Cheng-Ming
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [9] Clinical outcomes in end stage renal disease on dialysis and severe coronary artery disease: A real-world study
    Koh, Samuel Ji Quan
    Yap, Jonathan
    Jiang, Yilin
    Sng, Gerald Gui Ren
    Low, Yi Hua
    Lau, Yee How
    Sin, Yoong Kong Kenny
    Yeo, Khung Keong
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 378 : 105 - 110
  • [10] Safety Outcomes of Apixaban Compared With Warfarin in Patients With End-Stage Renal Disease
    Sarratt, Stefanie C.
    Nesbit, Ross
    Moye, Robert
    ANNALS OF PHARMACOTHERAPY, 2017, 51 (06) : 445 - 450
12345